GlassScriptPhysician profile
Ronald G Berger
NPI 1730109851
$150,077.94
in general payments reported to CMS, 2019-2025
36 companies · $2,137 in 2025
The $2,137 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,899 · 2020: $347 · 2021: $16K · 2022: $39K · 2023: $43K · 2024: $43K · 2025: $2,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $80K · Food and Beverage: $8,410 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,725.00 |
| Food and Beverage | $8,410.28 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $129,254.77 | 2021-2024 | Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $6,829.05 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $2,401.37 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $1,997.51 | 2019-2025 | Opsumit, Xarelto, Uptravi |
| Novartis Pharmaceuticals Corporation | $1,831.60 | 2019-2025 | |
| Medtronic, INC. | $1,327.20 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Amgen INC. | $1,052.89 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $874.68 | 2019-2025 | Farxiga, Brilinta, Wainua |
| E.R. Squibb & Sons, L.L.C. | $846.97 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $573.78 | 2019-2025 | Watchman Flx, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $438.49 | 2019-2021 | |
| Pfizer INC. | $413.62 | 2019-2025 | |
| Abbott Laboratories | $285.49 | 2020-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Sanofi-Aventis U.S. LLC | $207.35 | 2022 | |
| Edwards Lifesciences Corporation | $201.51 | 2022-2024 | Sapien 3 Ultra Resilia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $175.95 | 2023 | Optimizer |
| Medtronic Vascular, INC. | $167.69 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $128.73 | 2024 | Arcalyst |
| Cvrx, INC. | $115.91 | 2023 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $113.79 | 2024-2025 | Uptravi, Opsumit |
| Biosense Webster, INC. | $110.58 | 2024-2025 | Carto 3 |
| Janssen Scientific Affairs, LLC | $102.62 | 2022 | |
| Merck Sharp & Dohme LLC | $99.35 | 2023-2024 | Verquvo |
| Abiomed | $91.83 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $59.11 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $54.97 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $51.64 | 2025 | Onpattro |
| Philips North America LLC | $51.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.86 | 2025 | |
| Esperion Therapeutics, INC. | $42.62 | 2022-2025 | Nexletol |
| Davol INC. | $25.84 | 2025 | Progel Applicator Spray Tips |
| Coloplast Corp | $25.07 | 2024 | |
| Ionis Pharmaceuticals, INC. | $23.77 | 2025 | Tryngolza |
| Chiesi USA, INC. | $20.36 | 2023 | Cleviprex, Kengreal |
| Lantheus Medical Imaging, INC. | $18.02 | 2025 | |
| Lilly USA, LLC | $14.71 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.